Altana Pharma/Nycomed — North Dartmouth, Massachusetts

Altana Pharma/Nycomed is a clinical research site located in North Dartmouth, Massachusetts, United States 02747.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Altana Pharma/Nycomed has participated in 3 clinical trials.

Therapeutic areas: Hay Fever, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Dartmouth

Browse all research sites in Massachusetts · View every site in North Dartmouth

• Southcoast Hospital
• NorthEast Medical Research Associates
• GSK Investigational Site
• Research Site
• Infinity Medical Research
• Pfizer Investigational Site
• Novartis Investigative Site
• Boston Neuro Research Center
• Novo Nordisk Investigational Site
• Forest Investigative Site 1029
• Clinical Research Site
• Forest Investigative Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Altana Pharma/Nycomed?

Altana Pharma/Nycomed has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Altana Pharma/Nycomed conducted?

Altana Pharma/Nycomed has 3 clinical trials on record. Their work covers Hay Fever, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis.

Is Altana Pharma/Nycomed accredited by Crixeo Clinical Trials?

Altana Pharma/Nycomed has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Altana Pharma/Nycomed?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.